Gold tier: mechanically validated evidence, with its primary source.
1,729 evidence items · page 13 / 70
0.3 %State-level HIV prevalence in Nigeria ranged from 0.3% to 4.3% based on data from the Nigeria HIV/AIDS Indicator and Impact Survey (NAIIS) conducted from July to December 2018.
NigeriaVIH/sidaobserved 2018published 2022PloS onePubMeddocument of 5 observations
40 %The proportion of viral non-suppressed participants among youth living with HIV in Nigeria was 40% at baseline.
NigeriaVIH/sidaobserved 2021published 2025AIDS and behaviorPubMeddocument of 2 observations
1.9 %Women aged 15 to 49 years in Nigeria have an HIV prevalence rate of 1.9%.
NigeriaVIH/sidapublished 2022The Pan African medical journalPubMeddocument of 2 observations
500,000 peopleBased on NAIIS results, funds were provided to place an additional 500,000 HIV-positive Nigerians on antiretroviral therapy by the end of 2020.
NigeriaVIH/sidaobserved 2020published 2021Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 6 observations
0.5 %The prevalence of HIV in the study population was 0.5%.
NigeriaVIH/sidapublished 2025American journal of clinical pathologyPubMeddocument of 5 observations
6 %Only 6% of women had HIV tests during labour.
NigeriaVIH/sidaobserved 2013published 2020Journal of biosocial sciencePubMeddocument of 4 observations
0.316 rhoThere was a significant correlation between knowledge and practice of HIV PEP among doctors (Spearman's rho = 0.316, p < 0.05).
NigeriaVIH/sidapublished 2020West African journal of medicinePubMeddocument of 6 observations
22.7 %Three months after the intervention, the proportion of respondents with low dietary diversity significantly decreased from 42.7% to 22.7% in the study group.
NigeriaVIH/sidaobserved three months after the interventionpublished 2023African health sciencesPubMeddocument of 3 observations
90 %Viral load testing coverage among children and adolescents living with HIV remained high at 90% between baseline (October-December 2019) and endline (January-March 2021).
NigeriaVIH/sidaobserved January-March 2021published 2023PloS onePubMeddocument of 8 observations
2.3 aORThose who had disclosed their HIV status were twice as likely to adhere to HIV medication, with an adjusted odds ratio of 2.3.
NigeriaVIH/sidapublished 2021West African journal of medicinePubMeddocument of 3 observations
6.3 %Major PI resistance-associated mutation V82L was identified in 6.3% of CRF02_AG HIV-1 isolates.
NigeriaVIH/sidapublished 2020PloS onePubMeddocument of 11 observations
22.3 %Psychosocial variables contributed to variations in HIV-related stigma in Ottawa (22.3%), Miami (36.3%), and Port Harcourt (14.1%).
NigeriaVIH/sidapublished 2020Journal of racial and ethnic health disparitiesPubMeddocument of 5 observations
The majority of young people living with HIV are in sub-Saharan Africa.
NigeriaVIH/sidapublished 2021The patientPubMeddocument of 6 observations
35.8 %HIV testing and counseling (HTC) uptake among university students in Kano, Nigeria was 35.8%.
NigeriaVIH/sidapublished 2020International journal of STD & AIDSPubMeddocument of 2 observations
13.5 %Only 13.5% of the participants expressed the correct perceptions of the complementary relationship between HIV and TB.
Nigeriatuberculose · VIH/sidapublished 2024BMC public healthPubMeddocument of 4 observations
117 participantsThe study included 117 youth living with HIV/AIDS in Lagos State, Nigeria, with a mean age of 18.6 ± 2.6 years.
NigeriaVIH/sidaobserved 2022published 2025African journal of reproductive healthPubMeddocument of 7 observations
20.8 %The case fatality rate among HIV-positive mpox cases was 20.8% (5/24).
Nigeriampox · VIH/sidaobserved 2017-2019published 2023BMJ global healthPubMeddocument of 11 observations
50 %Women and girls account for more than 50% of the global HIV population.
NigeriaVIH/sidapublished 2024International journal of environmental research and public healthPubMeddocument of 2 observations
14.2 %Only 14.2% of children and young adolescents aged 0–14 years in Akwa-Ibom, Nigeria have been tested for HIV, according to the 2017 Akwa-Ibom AIDS Indicator Survey.
NigeriaVIH/sidaobserved 2017published 2021BMC pediatricsPubMed
4,190 patientsIn the post-MMD6 group, 4,190 patients were included.
NigeriaVIH/sidapublished 2023African journal of AIDS research : AJARPubMeddocument of 5 observations
200 cells/mm³Higher MTCT rates were associated with CD4 counts below 200 cells/mm.
NigeriaVIH/sidapublished 2026International journal of STD & AIDSPubMeddocument of 2 observations
6.7 %HIV positivity rate at the TB clinic was 6.7% (95% CI: 0.9–35.2%).
NigeriaVIH/sidapublished 2020PloS onePubMeddocument of 16 observations
11.7 %Recent facility-based HIV testing uptake was higher among adolescents and young adults (AYA) with one sexual partner in the past 3 months by an unadjusted risk difference of 11.7%, compared to AYA with no recent sexual partners.
NigeriaVIH/sidapublished 2026AIDS (London, England)PubMeddocument of 7 observations
33 monthsThe non-parametric median survival time of TB patients co-infected with HIV was 33 months.
Nigeriatuberculose · VIH/sidapublished 2020PloS onePubMeddocument of 4 observations
75.9 %The frequency of cognitive impairment among CART-exposed patients was 75.9% (41 out of 54 patients).
NigeriaVIH/sidapublished 2026Annals of African medicinePubMeddocument of 7 observations
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.